THINK Surgical Journey
2019
THINK Surgical, Inc. obtains U.S. FDA 510(k) clearance to market the TSolution One® Total Knee Application for use in total knee arthroplasty (TKA).
2018
THINK Surgical, Inc. completes U.S. FDA IDE clinical trial.
2017
THINK Surgical, Inc. is awarded the CE marking for TKA.
2017
The TSolution One Surgical System receives Korean FDA clearance for Total Hip Arthroplasty (THA) and Total Knee Arthroplasty (TKA).
2017
The TSolution One Surgical System receives U.S. FDA clearance for Total Hip Arthroplasty (THA).
2016
The 1989 ROBODOC® prototype, the TSolution One core technology, was added to the Smithsonian National Museum of American History as part of their Science and Medicine Collection.
2015
THINK Surgical, Inc. receives FDA 510(k) clearance for Femoral Canal and Acetabular Cup Preparation.
2014
THINK Surgical, Inc. becomes the new name of Curexo Technology Corporation.
2014
The TSolution One® receives FDA 510(k) clearance and and CE marking for Femoral Canal Preparation during THA.
2010
The first ROBODOC® Surgical System is established at Sutter General Hospital in Sacramento, CA
2008
The ROBODOC Surgical System receives FDA 510(k) clearance for THA.
2003
Total Knee Arthroplasty (TKA) Surgical System was introduced in Korea, Japan and India
2000
The ROBODOC Surgical System is introduced to Europe for TKA.
1994
The ROBODOC Surgical System is introduced to Europe for THA.
1992
The ROBODOC team receives the Computerworld Smithsonian Award for Innovation in the Arts and Sciences.
1992
The ROBODOC Surgical System assists a surgeon in a THA procedure−making medical history.
1986
Researchers from IBM and the University of California, Davis, begin collaborative development of an innovative robotic surgical system for THA.